Skip to content

Immatics

US · IMTX #3173 by market cap Listed 2018
7.45 -0.05 -0.67%
Live - 5344 symbols - heartbeat 293s ago · 2026-10-08 05:54
Pre-market 7.40 -0.67%
After-hours 7.88 +5.77%
Overnight 7.46 +0.13%
Market cap
1.11B
P/B
2.49
EPS
-1.80
Reader sentiment Are you bullish or bearish on IMTX?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Mizuho Securities Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $25
    Market Newswire · 2026/8/20
  • Rating change
    TD Cowen Maintains Immatics(IMTX.US) With Buy Rating
    Market Newswire · 2026/8/19
  • Rating change
    Analysts Conflicted on These Healthcare Names: Siemens Healthineers AG (OtherSEMHF), Immatics (IMTX) and Aardvark Therapeutics, Inc. (AARD)
    TipRanks · 2026/3/24
  • Rating change
    Goldman Sachs Maintains Immatics(IMTX.US) With Buy Rating, Raises Target Price to $12.2
    Market Newswire · 2026/5/13
  • Goldman Sachs Maintains Immatics(IMTX.US) With Buy Rating, Cuts Target Price to $11.8
    Market Newswire · 2026/8/19
  • Jefferies Maintains Immatics(IMTX.US) With Buy Rating, Cuts Target Price to $17
    Market Newswire · 2026/8/26
  • Rating change
    Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD), Immatics (IMTX) and BrightSpring Health Services, Inc. (BTSG)
    TipRanks · 2026/3/16
  • Rating change
    Mizuho Securities Maintains Immatics(IMTX.US) With Buy Rating, Raises Target Price to $23
    Market Newswire · 2025/11/19
  • Rating change
    Mizuho Securities Maintains Immatics(IMTX.US) With Buy Rating, Announces Target Price $25
    Market Newswire · 2026/2/19
  • Rating change
    Jefferies Initiates Immatics(IMTX.US) With Buy Rating, Announces Target Price $18
    Market Newswire · 2026/3/16
  • Earnings Flash (IMTX) Immatics Posts Q2 Revenue 9.1M Euros, Vs. FactSet Est of 10.4M Euros
    MT Newswires · 2026/8/18
  • BofA Securities Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $17
    Market Newswire · 2026/8/19
  • Rating change
    TD Cowen Initiates Immatics(IMTX.US) With Buy Rating
    Market Newswire · 2026/4/28
  • Rating change
    BofA Securities Maintains Immatics(IMTX.US) With Buy Rating, Raises Target Price to $17
    Market Newswire · 2026/1/6
  • Rating change
    Chardan Capital Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $25
    Market Newswire · 2026/5/20
  • Rating change
    Mizuho Securities Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $23
    Market Newswire · 2025/12/8
  • Rating change
    Guggenheim Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $19
    Market Newswire · 2026/5/13
  • Rating change
    Clear Street Initiates Immatics(IMTX.US) With Buy Rating, Announces Target Price $18
    Market Newswire · 2025/12/12
  • Rating change
    Guggenheim Maintains Immatics(IMTX.US) With Buy Rating, Raises Target Price to $19
    Market Newswire · 2025/11/18
  • Rating change
    Leerink Partners Maintains Immatics(IMTX.US) With Buy Rating, Announces Target Price $17
    Market Newswire · 2026/3/6

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 05:54:03 · For reference only, not investment advice and not tailored to your situation.